-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Indian Ministry of Health said on the 6th that the Indian side has begun to test 4 kinds of cold and cough syrup samples
produced by India Maiden Pharmaceutical Co.
, Ltd.
and exported to the West African country Gambia.
A day earlier, the World Health Organization had issued a warning that the 4 syrups could be linked
to the deaths of 66 children in the Gambia.
produced by India Maiden Pharmaceutical Co.
, Ltd.
and exported to the West African country Gambia.
A day earlier, the World Health Organization had issued a warning that the 4 syrups could be linked
to the deaths of 66 children in the Gambia.
WHO said laboratory analysis showed that the levels of two contaminants, diethylene glycol and ethylene glycol, in the syrup were "unacceptable" and that these toxic components could lead to acute kidney injury
.
.
Reuters quoted India's Ministry of Health as reporting that the syrup samples exported to the Gambia have been sent back to Indian laboratories for testing, and the government will take follow-up measures
based on the test results.
In addition, India has asked WHO to share its report identifying a causal relationship between syrup and deaths
.
based on the test results.
In addition, India has asked WHO to share its report identifying a causal relationship between syrup and deaths
.
As for when to share the report, WHO spokeswoman Margaret Harris did not respond to a reporter's enquiry
.
She said information provided by Maiden Pharmaceuticals and India indicated that investigators had gone to the company's factory and that WHO was awaiting the results of the Indian investigation
.
.
She said information provided by Maiden Pharmaceuticals and India indicated that investigators had gone to the company's factory and that WHO was awaiting the results of the Indian investigation
.
Maiden Pharmaceuticals has two plants
in Haryana.
Haryana Health Minister Anil Vijay said authorities would take drastic measures
if improper conditions were found.
in Haryana.
Haryana Health Minister Anil Vijay said authorities would take drastic measures
if improper conditions were found.
According to Reuters, the WHO informed Indian regulators of child deaths in the Gambia later last month, and India has launched an investigation
with WHO.
with WHO.
Maiden Pharmaceuticals executives Naresh Kumar Goyar said Maiden Pharmaceuticals was trying to pinpoint the situation
.
The company's main business is the production, export and supply of pharmaceuticals, including a wide range of capsules, ointments, syrups and tablets
.
.
The company's main business is the production, export and supply of pharmaceuticals, including a wide range of capsules, ointments, syrups and tablets
.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
